This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Global Pharmaceutical Regulatory Affairs Summit
22-24 October 2024
Sheraton Brussels Airport, BrusselsHybrid Event

Craig Anderson
Director, R&D Labeling Lead at Pfizer


As Director, R&D Lead at Pfizer, Craig Anderson is responsible for research, development, business and process-related functions across the International Labeling organisation. This includes topics such as electronic labelling, medicinal product information, digital health, and data standards.

In addition to having biopharmaceutical industry experience, Craig also has regulator experience from Health Canada where he led various informatics projects ranging from the IDMP to Structured Product Labelling.

Craig is also Co-lead of HL7’s Vulcan accelerator project for electronic Product Information (ePI) and co-lead for HL7 BR&R's Pharmaceutical Quality (Industry Use Case) project.

Agenda Sessions

  • Developing the Fast Healthcare Interoperability Resources (FHIR)